Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Prostatic Neoplasms 21Lymphoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Large B-Cell, Diffuse 13Lymphoma, Non-Hodgkin 8Lymphoma, Follicular 7Leukemia 6Hodgkin Disease 6Neoplasm Metastasis 5Lymphoma, B-Cell 4Burkitt Lymphoma 4Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell, Marginal Zone 3Hemangioma 3Recurrence 2Neoplasms 2Neoplasm, Residual 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Dendritic Cell Sarcoma, Interdigitating 2Breast Neoplasms 2Thymoma 1Stomatitis 1Prostate Cancer Metastatic 1Philadelphia Chromosome 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Acupuncture Therapy 4Paclitaxel 3Exercise 3Duloxetine Hydrochloride 3Surveys and Questionnaires 2Physical Therapy Modalities 2Glutamine 2Acetylcysteine 2ziconotide 1sagopilone 1nabilone 1glutamic acid diethyl ester 1eribulin 1allantoicase 1Yoga 1Vitamin B Complex 1Ultrasonic Therapy 1Trimetazidine 1Thioctic Acid 1Therapeutic Touch 1Tadalafil 1Sugars 1Sodium Chloride 1Sirolimus 1Saline Solution 1Prednisolone 1Pentoxifylline 1Pain Management 1Omeprazole 1Omacor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Peripheral Nervous System Diseases × Prednisolone × Clear all
NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Bayer

Phase 2 Completed
150 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡